Obesity Care Today: Making Sense of New Guidelines and GLP-1 Options

This webinar reviews newly released obesity guidelines and examines how they are shaping the role of GLP-1–based therapies in obesity care. Participants will explore key updates in diagnosis, treatment pathways, and long-term management, with attention to benefits, limitations, and areas of ongoing debate. The session emphasizes practical understanding to support informed, patient-centered conversations about obesity treatment.

Key Takeaways

• Summarize key updates in current obesity clinical practice guidelines
• Describe the role of GLP-1 receptor agonists within guideline-recommended obesity treatment pathways, including benefits and limitations.
• Apply guideline-informed principles to support patient-centered discussions about obesity care without making specific treatment recommendations.

About the Speaker

Dr. Diab is a diabetologist and weight management specialist. She runs a multi-disciplinary practice specializing in the management of chronic diseases, particularly diabetes and obesity. Her approach is to walk the journey with her patients and to allow them to manage their disease rather than allow the disease to define who they are. Dr. Diab has been the recipient of numerous National and International Awards including the National CDE (Centres of Diabetes & Endocrinology) Best Practice Award in 2016 and the International Rising Stars Diabetes Programme in 2020.